ImmunoACT Revenue and Competitors
Employee Data
- ImmunoACT has 147 Employees.
- ImmunoACT grew their employee count by 46% last year.
ImmunoACT's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder | Reveal Email/Phone |
2 | Assistant Manager | Reveal Email/Phone |
3 | Project Manager | Reveal Email/Phone |
4 | Assistant Manager | Reveal Email/Phone |
5 | Project Manager | Reveal Email/Phone |
6 | Finance Manager | Reveal Email/Phone |
7 | Assistant Manager (Facility & Operations) | Reveal Email/Phone |
8 | Scientist-III | Reveal Email/Phone |
9 | Principal Scientist | Reveal Email/Phone |
10 | Quality Assurance Executive | Reveal Email/Phone |
ImmunoACT Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 147 | 46% | N/A | N/A |
#2 | N/A | 488 | 72% | N/A | N/A |
#3 | N/A | 478 | 30% | N/A | N/A |
#4 | N/A | 11 | 10% | N/A | N/A |
#5 | N/A | 20 | 18% | N/A | N/A |
#6 | N/A | 98 | 88% | $16.6M | N/A |
#7 | N/A | 14 | 17% | N/A | N/A |
#8 | N/A | 7 | 75% | N/A | N/A |
What Is ImmunoACT?
Spun-out from IIT-Bombay in 2018, ImmunoACT is India's pioneer of Gene-modified Cell Therapies, having launched the country's first CAR-T cell therapy for treatment of certain B-cell malignancies. With a rapidly expanding pipeline beginning, our mission is to provide affordable access to novel CAR-T cell therapies.
keywords:N/AN/A
Total Funding
147
Number of Employees
N/A
Revenue (est)
46%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.3M | 158 | -4% | N/A |
#2 | $21.4M | 159 | 8% | N/A |
#3 | N/A | 159 | 23% | N/A |
#4 | $18.2M | 164 | 24% | N/A |
#5 | $9.2M | 168 | 14% | N/A |